These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22488776)

  • 1. Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake.
    Al Kobiasi M; Chua BY; Tonkin D; Jackson DC; Mainwaring DE
    J Biomed Mater Res A; 2012 Jul; 100(7):1859-67. PubMed ID: 22488776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q; Wang T; Cochrane C; McCarron P
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines.
    Chua BY; Al Kobaisi M; Zeng W; Mainwaring D; Jackson DC
    Mol Pharm; 2012 Jan; 9(1):81-90. PubMed ID: 22149016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and optimization of chitosan nanoparticles and magnetic chitosan nanoparticles as delivery systems using Box-Behnken statistical design.
    Elmizadeh H; Khanmohammadi M; Ghasemi K; Hassanzadeh G; Nassiri-Asl M; Garmarudi AB
    J Pharm Biomed Anal; 2013 Jun; 80():141-6. PubMed ID: 23571126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
    Gordon S; Saupe A; McBurney W; Rades T; Hook S
    J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging.
    Ranjan AP; Zeglam K; Mukerjee A; Thamake S; Vishwanatha JK
    Nanotechnology; 2011 Jul; 22(29):295104. PubMed ID: 21693801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].
    Yang XR; Zong L; Yuan XY
    Yao Xue Xue Bao; 2007 Jul; 42(7):774-9. PubMed ID: 17882964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, size control and fluorescence studies of gold nanoparticles in carboxymethylated chitosan aqueous solutions.
    Huang L; Zhai M; Peng J; Xu L; Li J; Wei G
    J Colloid Interface Sci; 2007 Dec; 316(2):398-404. PubMed ID: 17707389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan microparticles for the controlled delivery of fluoride.
    Keegan GM; Smart JD; Ingram MJ; Barnes LM; Burnett GR; Rees GD
    J Dent; 2012 Mar; 40(3):229-40. PubMed ID: 22212236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of processing parameters on particle size of ultrasound prepared chitosan nanoparticles: an Artificial Neural Networks Study.
    Esmaeilzadeh-Gharedaghi E; Faramarzi MA; Amini MA; Rouholamini Najafabadi A; Rezayat SM; Amani A
    Pharm Dev Technol; 2012; 17(5):638-47. PubMed ID: 22681416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC; Chiang CH; Yeh MK
    J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxymethyl chitosan as a matrix material for platinum, gold, and silver nanoparticles.
    Laudenslager MJ; Schiffman JD; Schauer CL
    Biomacromolecules; 2008 Oct; 9(10):2682-5. PubMed ID: 18816099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
    Singh KH; Shinde UA
    Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles.
    Yue ZG; Wei W; Lv PP; Yue H; Wang LY; Su ZG; Ma GH
    Biomacromolecules; 2011 Jul; 12(7):2440-6. PubMed ID: 21657799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linolenic acid-modified chitosan for formation of self-assembled nanoparticles.
    Liu CG; Desai KG; Chen XG; Park HJ
    J Agric Food Chem; 2005 Jan; 53(2):437-41. PubMed ID: 15656685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan.
    Chiu YL; Ho YC; Chen YM; Peng SF; Ke CJ; Chen KJ; Mi FL; Sung HW
    J Control Release; 2010 Aug; 146(1):152-9. PubMed ID: 20580915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinol-encapsulated low molecular water-soluble chitosan nanoparticles.
    Kim DG; Jeong YI; Choi C; Roh SH; Kang SK; Jang MK; Nah JW
    Int J Pharm; 2006 Aug; 319(1-2):130-8. PubMed ID: 16713152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.